UBS Maintains Neutral on Alignment Healthcare, Lowers Price Target to $6
Portfolio Pulse from richadhand@benzinga.com
UBS analyst Kevin Caliendo maintains a Neutral rating on Alignment Healthcare (NASDAQ:ALHC) and lowers the price target from $8 to $6.
July 13, 2023 | 1:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
UBS analyst Kevin Caliendo has lowered the price target for Alignment Healthcare from $8 to $6, while maintaining a Neutral rating.
The lowering of the price target by a UBS analyst from $8 to $6 indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price. The Neutral rating suggests that the analyst does not see significant upside or downside from the current price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100